CTOs on the Move

BioMarin

www.BioMarin.com

 
BioMarin Pharmaceutical Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Novato, CA. To find more information about BioMarin Pharmaceutical Inc., please visit www.bmrn.com
  • Number of Employees: 1K-10K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details
David Shiao
Director - Information Technology Security and Compliance Profile

Funding

BioMarin raised $720M on 08/10/2016

Similar Companies

Les Restaurants Pacini

Les Restaurants Pacini is a La Prairie, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MAKO Surgical Corp.

MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for minimally invasive orthopedic knee procedures.

MicroVention Inc

The Company was founded in April 1997 by Robert Rosenbluth and Brian Cox and incorporated as MicroVention, Inc. in September.

Grason Stadler

Grason Stadler is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.